수면무호흡증 기기 - 시장 인사이트, 경쟁 구도, 예측(2032년)

Sleep Apnea Devices Market Summary

• The global sleep apnea devices market is expected to increase from USD 9,561.14 million in 2024 to USD 15,839.98 million by 2032, reflecting strong and sustained growth.
• The global sleep apnea devices market is growing at a CAGR of 6.58% during the forecast period from 2025 to 2032.
• The market of sleep apnea devices is being primarily driven by the Increasing prevalence of obstructive sleep apnea (OSA), its associated risk factors, increasing public health initiatives and awareness campaigns, technological advancements in the product designs, and an increase in product development activities among the key market players.
• The leading companies operating in the sleep apnea devices market include Koninklijke Philips N.V., ResMed, Fisher & Paykel Healthcare Limited, and AMBULANCE (SHENZHEN) TECH. CO. LTD, BMC, Beijing Aeonmed Co., Ltd., Hebei Topson Medical Technology Co., Ltd., Hunan VentMed Medical Technology Co., Ltd., Vivos Therapeutics, Inc., Guangdong Pigeon Medical Apparatus Co., Ltd., Nihon Kohden Corporation, Natus Medical Incorporated, SOMNOmedics GmbH, VYAIRE, Compumedics Limited, Drive DeVilbiss International, Nox Medical, eXciteOSA Inc., BPL Medical Technologies, Elmaslar Medikal A.S., BMC, and others.
• North America is expected to dominate the overall sleep apnea devices market. The region's market growth is primarily driven by the increasing prevalence of sleep apnea and insomnia, the rising geriatric population base in the region, and the rising chronic nasal congestion. Additionally, increased government initiatives coupled with increased awareness programs about sleep apnea devices, and the presence of key market players engaged in mergers, acquisitions, product launches, and other market activities across the region, are boosting the market of sleep apnea devices across the region.
• In the product type segment of the sleep apnea devices market, the Positive Airway Pressure (PAP) category is estimated to account for the largest market share in 2024.

Factors Contributing to the Growth of the Sleep Apnea Devices Market

• Increasing prevalence of obstructive sleep apnea devices and associated risk factors leading to a surge in sleep apnea devices: The increasing prevalence of obstructive sleep apnea devices (OSA) and its associated comorbidities, such as obesity, aging populations, hypertension, heart failure, and arrhythmias, are significantly driving the growth of the sleep apnea market. As these conditions increase the risk and severity of OSA, more patients require timely diagnosis and effective treatment. This growing patient pool directly fuels the demand for CPAP, BiPAP, oral appliances, and advanced diagnostic solutions, thereby accelerating overall market growth.
• Increasing public health initiatives and awareness campaigns: Increasing public health initiatives and awareness campaigns are significantly boosting the sleep apnea devices market by improving disease recognition, early diagnosis, and treatment adoption. Government agencies, healthcare organizations, and patient advocacy groups are actively promoting education on the risks of untreated sleep apnea, such as cardiovascular complications, diabetes, and reduced quality of life. These initiatives encourage more individuals to undergo sleep studies and seek timely intervention, thereby driving demand for CPAP machines, oral appliances, and diagnostic tools. Enhanced awareness also reduces the stigma around sleep-related disorders, leading to higher patient compliance and sustained market growth.
• Technological advancement in product design: Modern CPAP and BiPAP machines are now quieter, lighter, and more portable, improving patient compliance. Innovations like smart connectivity, cloud-based monitoring, and wearable diagnostic tools allow doctors to track progress remotely, while custom-fit oral appliances and implantable devices offer less invasive alternatives. These improvements not only enhance patient experience but also encourage more people to adopt and stick with treatment, driving market growth.

Sleep Apnea Devices Market Report Segmentation

This sleep apnea devices market report offers a comprehensive overview of the global Sleep Apnea Devices market, highlighting key trends, growth drivers, challenges, and opportunities. It covers detailed market segmentation by Product Type (Therapeutic Device [Positive Airway Pressure (PAP), Oral Appliances, Oxygen Devices, and Others] and Diagnostic Device [Pulse Oximeter, Polysomnography Devices (PSG), and Actigraphy Devices]), Portability (Portable and Non Portable), End-User (Hospital & Clinics, Home Healthcare, and Others), and geography. The report provides valuable insights into the competitive landscape, regulatory environment, and market dynamics across major markets, including North America, Europe, and Asia-Pacific. Featuring in-depth profiles of leading industry players and recent product innovations, this report equips businesses with essential data to identify market potential, develop strategic plans, and capitalize on emerging opportunities in the rapidly growing sleep apnea devices market.

A sleep apnea device is a medical device used to treat sleep apnea, a condition where a person's breathing repeatedly stops and starts during sleep. These devices are designed to keep the airway open, allowing for continuous and uninterrupted breathing, which helps improve sleep quality and prevent the serious health complications associated with the disorder, such as heart disease, high blood pressure, and stroke.

The demand for sleep apnea devices is being significantly boosted by the growing global prevalence of sleep apnea and the rising population with obesity. This market expansion is further driven by key factors such as the increasing adoption of advanced technologies, a rise in public and professional awareness about the condition, the growth of the geriatric population, and a steady increase in new product launches and approvals. These combined trends are projected to sustain the overall growth of the sleep apnea devices market from 2025 to 2032.

What are the latest Sleep Apnea Devices Market Dynamics and Trends?

The sleep apnea devices market is gaining momentum, driven by the rising prevalence of obstructive sleep apnea (OSA) and its associated comorbidities, including obesity, aging populations, hypertension, heart failure, and arrhythmias. According to DelveInsight analysis (2024), an estimated 937 million adults worldwide suffer from mild to severe OSA. In the UK alone, approximately 10.5 million people were affected in 2023, with up to 4 million experiencing moderate to severe forms of the condition.

Obesity remains a major risk factor, with around 2.6 billion adults globally overweight and 890.5 million living with obesity in 2024. Since OSA is strongly linked to obesity, aging, and chronic diseases such as hypertension, diabetes, and cardiovascular disorders, its incidence continues to climb. Growing awareness of the serious health risks of untreated OSA has led to more diagnoses and treatment adoption, fueling demand for CPAP and BiPAP machines, oral appliances, diagnostic tools, and emerging therapies.

Awareness initiatives, such as the World Sleep Society's World Sleep Day, are further supporting market growth by educating the public about the importance of healthy sleep and the dangers of sleep disorders. This increased recognition is translating into higher diagnostic rates and rising uptake of PAP devices, masks, and advanced sleep apnea solutions.

Market players are also advancing innovation. For example, in August 2025, the FDA approved Nyxoah's Genio System, a leadless, battery-free, bilateral hypoglossal nerve stimulator with a wearable, upgradeable component for treating moderate to severe OSA. Such breakthroughs highlight the industry's focus on patient-friendly and effective alternatives beyond traditional PAP therapy.

While the sleep apnea device market is growing, it faces significant barriers. High costs are a major challenge, especially for PAP (Positive Airway Pressure) systems. A new CPAP machine can cost several hundred to over a thousand dollars, and that doesn't include the ongoing expenses for replacement masks, tubing, and filters. This can be a substantial financial burden, particularly for those with limited or no health insurance coverage.

Another key barrier is the potential for complications related to implantable devices. Though these devices, like hypoglossal nerve stimulators, offer a mask-free alternative, they require a surgical procedure. As with any surgery, there are risks, including infection, nerve damage, persistent pain at the implant site, and allergic reactions to the device materials. Additionally, some patients may experience side effects after the device is activated, such as tongue discomfort, dry mouth, or problems with speaking and swallowing. These complications can affect a patient's willingness to adopt this technology and may require further medical intervention or device removal.

Sleep Apnea Devices Market Segment Analysis

Sleep Apnea Devices Market by Product Type (Therapeutic Device [Positive Airway Pressure (PAP), Oral Appliances, Oxygen Devices, and Others] and Diagnostic Device [Pulse Oximeter, Polysomnography Devices (PSG), and Actigraphy Devices]), Portability (Portable and Non Portable), End-User (Hospital & Clinics, Home Healthcare, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

By Product Type: Positive Airway Pressure (PAP) Category Dominates the Market

Within the therapeutic devices segment of the sleep apnea devices market, the Positive Airway Pressure (PAP) category is projected to hold the largest share, accounting for approximately 65% in 2024. This dominance is attributed to its strong clinical efficacy and widespread adoption over alternatives such as oral appliances and adaptive servo-ventilation devices, which, while growing, remain comparatively niche solutions. Positive Airway Pressure (PAP) therapy is significantly boosting the overall market of sleep apnea devices, as it remains the gold standard treatment for obstructive sleep apnea (OSA) due to its proven clinical effectiveness in keeping the airway open during sleep. Continuous PAP (CPAP), Bi-level PAP (BiPAP), and Auto-adjusting PAP (APAP) devices are widely prescribed by sleep specialists because they reduce apnea episodes, improve oxygen levels, and enhance sleep quality, which directly lowers the risks of associated comorbidities such as hypertension, cardiovascular disease, and stroke.

Additionally, the latest development in the realm of Positive Airway Pressure (PAP) therapy and related sleep apnea treatments are further boosting the market of positive airway pressure market.

For instance, in April 2024, Researchers at the University of Cincinnati announced that they were developing a VortexPAP device that employs vortex airflow technology. Early clinical studies found it delivers therapeutic pressure levels comparable to conventional CPAP machines, yet uses a minimalistic, non-sealing interface that's far less intrusive and more comfortable, especially promising for individuals with claustrophobia or discomfort from traditional masks.

By Portability: Portable Category Dominates the Market

In the portability segment of the sleep apnea devices market, the portable category is estimated to account for the largest market share in 2024. Portable sleep apnea devices are boosting the overall market by making diagnosis and treatment more accessible, convenient, and patient-friendly. Unlike traditional bulky systems, portable CPAP machines and home sleep testing devices allow patients to manage their condition while traveling or in the comfort of their homes, improving compliance and comfort. Their ease of use, compact design, and integration with mobile apps for real-time monitoring are attracting a wider patient base, especially those reluctant to undergo in-lab sleep studies.

For instance, in April 2025, FDA-cleared, fully disposable home sleep apnea test NightOwl. It is designed to offer healthcare providers a simplified, accurate, and efficient way to diagnose obstructive sleep apnea (OSA) from the comfort of an individual's home. This growing preference for mobility and home-based care is driving higher adoption, thereby expanding the sleep apnea devices market globally.

By End-User: Hospitals & Clinics Dominate the Market

Hospitals and clinics are boosting the overall market of sleep apnea devices by serving as the primary centers for diagnosis, treatment, and patient education. With access to advanced diagnostic tools like polysomnography (PSG) and home sleep testing kits, they play a critical role in identifying undiagnosed cases of obstructive sleep apnea (OSA). These facilities also drive demand for therapeutic devices such as CPAP, BiPAP, and oral appliances through prescription and long-term patient management programs. Moreover, growing investments in sleep centers within hospitals, rising referrals from specialists, and the integration of telemedicine for follow-ups are expanding patient access and compliance, thereby accelerating the adoption of sleep apnea devices globally.

Sleep Apnea Devices Market Regional Analysis

North America Sleep Apnea Devices Market Trends

North America is projected to dominate the global sleep apnea devices market in 2024, accounting for over 45% of the total share. This leadership is driven by the rising prevalence of sleep apnea, insomnia, and chronic nasal congestion, coupled with the region's expanding geriatric population. Strong government initiatives, growing awareness campaigns, and the active presence of key players engaging in mergers, acquisitions, and product launches are further accelerating market adoption.

According to DelveInsight analysis (2024), the U.S. reported ~16.5 million diagnosed prevalent cases of COPD, significantly boosting demand for diagnostic tools such as polysomnography and home sleep apnea tests, as well as therapeutic solutions including CPAP, BiPAP, oral appliances, and hypoglossal nerve stimulation devices. Awareness initiatives are also shaping growth, such as the Alliance of Sleep Apnea Partners' global GASP campaign launched on World Sleep Day (March 12, 2025), which emphasized the seriousness of sleep apnea with the tagline "Life is one breath away!" Additionally, product approvals are strengthening the market outlook. For example, in December 2024, Movano Health received FDA 510(k) clearance for the pulse oximeter feature in its EvieMed smart ring, supporting its use in chronic disease management. Collectively, these factors position North America as the key growth engine of the global sleep apnea devices market.

Europe Sleep Apnea Devices Market Trends

Europe is playing a significant role in driving the growth of sleep apnea devices, fueled by the rising prevalence of obstructive sleep apnea (OSA) linked to aging populations, obesity, and lifestyle-related disorders. The region has a strong focus on early diagnosis and treatment due to a well-established healthcare infrastructure and supportive government initiatives aimed at addressing sleep-related disorders. Growing awareness campaigns led by organizations such as the European Sleep Research Society and national health authorities are encouraging individuals to seek timely diagnosis and treatment. Additionally, increasing investments in sleep laboratories, adoption of advanced technologies like portable and home-based diagnostic devices, and the strong presence of global as well as regional medical device manufacturers are boosting product innovation and accessibility. For instance, in June 2025, Samsung secured CE marking for its Sleep Apnea feature within the Galaxy Watch series, enabling availability across 34 European markets, as well as in Australia and Singapore. This expansion means that users in Europe can now monitor signs of moderate to severe obstructive sleep apnea (OSA) directly via their Galaxy Watch through the Samsung Health Monitor app.

Asia-Pacific Sleep Apnea Devices Market Trends

Asia-Pacific is emerging as a major growth driver for the sleep apnea devices market due to its rapidly rising patient pool, fueled by increasing obesity, aging populations, and growing cases of obstructive sleep apnea (OSA). DelveInsight estimates indicate that in 2023, the obstructive sleep apnea gender-specific diagnosed prevalence in Japan was approximately 3,193 thousand cases for males and 1,820 thousand cases for females.

Additionally, the improved healthcare infrastructure and expanding access to diagnostic and therapeutic devices are further driving adoption in countries like China, India, and Japan. For instance, in January 2025, ResMed officially introduced the AirSense 11, its advanced CPAP device, to the Indian market. Furthermore, government initiatives, awareness programs, and the entry of global as well as local players offering affordable portable solutions are making sleep apnea devices more accessible, thereby significantly boosting the overall market in the region.

Who are the major players in the Sleep Apnea Devices market?

The following are the leading companies in the sleep apnea devices market. These companies collectively hold the largest market share and dictate industry trends.

• Koninklijke Philips N.V.
• ResMed
• Fisher & Paykel Healthcare Limited
• AMBULANCE (SHENZHEN) TECH. CO. LTD
• Beijing Aeonmed Co., Ltd.
• Hebei Topson Medical Technology Co., Ltd.
• Hunan VentMed Medical Technology Co., Ltd.
• Vivos Therapeutics, Inc.
• Guangdong Pigeon Medical Apparatus Co., Ltd.
• Nihon Kohden Corporation
• Natus Medical Incorporated
• SOMNOmedics Gmbh
• VYAIRE
• Compumedics Limited
• Drive DeVilbiss International
• Nox Medical
• eXciteOSA Inc.
• BPL Medical Technologies
• Elmaslar Medikal A.S.
• BMC
• Others

How is the competitive landscape shaping the sleep apnea devices market?

The competitive landscape of the sleep apnea devices market is moderately concentrated, with a few global leaders holding significant market share while regional players and startups are steadily expanding their presence. Companies like ResMed, Philips Respironics, Fisher & Paykel Healthcare, and Lowenstein Medical dominate the market with a strong portfolio of CPAP, BiPAP, masks, and digital health solutions, leveraging advanced technologies and global distribution networks. Their focus on AI integration, cloud-based monitoring, and patient engagement apps has further strengthened their competitive edge. However, emerging players in Asia-Pacific, particularly in India, China, and Japan, are intensifying competition by offering cost-effective PAP devices, oral appliances, and home-based diagnostic tools, targeting the large undiagnosed population. The growing emphasis on portable, user-friendly devices and increasing adoption of home healthcare are driving opportunities for new entrants. While the market is concentrated among a few big players, the rise of regional innovators and strategic collaborations is gradually reshaping competition, making the landscape more dynamic.

Recent Developmental Activities in the Sleep Apnea Devices Market

• In May 2025, Zynex, Inc. announced the submission of a 510(k) application to the FDA for NiCO(TM), its noninvasive CO-oximeter device used in patient monitoring.
• In May 2025, Wesper secured FDA clearance for its innovative home sleep testing kit that directly measures airflow and respiratory effort, with no cannulas involved, improving comfort and accuracy for central and obstructive event detection.
• In February 2025, Huxley Medical announced that the FDA had cleared its SANSA home sleep apnea test to use cellular data upload, eliminating the need for Bluetooth or smartphone apps to transmit test data. This breakthrough simplifies the diagnostic process and addresses a common issue with failed home testing.
• In February 2025, the Viatom Smart Ring Pulse Oximeter, O2Ring, received FDA approval.
• In February 2025, PranaQ received FDA 510(k) clearance for TipTraQ, an AI-enabled, single-point-of-contact wearable that delivers comprehensive sleep and respiratory insights from home, including SpO2 monitoring and severity classification of apnea.

Sleep Apnea Devices Market Segmentation

• Sleep Apnea Devices by Product Type Exposure
• Therapeutic Device
• Positive Airway Pressure (PAP)
• Oral Appliances
• Oxygen Devices
• Others
• Diagnostic Device
• Pulse Oximeter
• Polysomnography Devices (PSG)
• Actigraphy Devices
• Sleep Apnea Devices Portability Exposure
• Portable
• Non Portable
• Sleep Apnea Devices End-Users Exposure
• Hospitals & Clinics
• Home Healthcare
• Others
• Sleep Apnea Devices Geography Exposure
• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Spain
• Rest of Europe
• Asia-Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia-Pacific
• Rest of the World
• South America
• Middle East
• Africa

Impact Analysis

AI-Powered Innovations and Applications:

AI-powered innovations are transforming the sleep apnea devices market by enabling smarter diagnosis, personalized therapy, and improved patient adherence. Modern CPAP and BiPAP devices from companies like ResMed and Philips now integrate AI algorithms that analyze breathing patterns in real time, automatically adjusting pressure levels for optimal comfort and treatment efficacy. AI-driven platforms are also enhancing remote patient monitoring, where data from connected devices is transmitted to cloud systems, allowing clinicians to track adherence, detect therapy issues early, and tailor interventions. Additionally, AI is being applied in home sleep testing devices and wearables, using machine learning to interpret complex biosignals such as airflow, oxygen saturation, and snoring, reducing the reliance on traditional sleep labs. Some startups are leveraging predictive AI models to identify patients at risk of sleep apnea through electronic health records and wearable data, thereby aiding early detection. Overall, AI applications are making sleep apnea devices more intelligent, patient-centric, and efficient in both treatment and diagnosis.

U.S. Tariff Impact Analysis on Sleep Apnea Devices Market:

The U.S. tariff landscape has introduced notable complexities for the sleep apnea devices market, particularly affecting manufacturers that rely on international supply chains. Recent trade policies imposed a general 10% tariff on most imported goods and a steep 145% tariff on products from China, which has raised concerns about increased production costs and consumer pricing. However, companies like ResMed have strategically benefited from exemptions under the Nairobi Protocol, which allows duty-free treatment for medical devices designed for individuals with chronic respiratory conditions. This exemption has shielded ResMed from the financial impact of these tariffs, giving it a competitive edge over rivals sourcing from high-tariff regions. Overall, while tariffs pose a challenge to cost structures and market access, strategic sourcing and regulatory exemptions are helping some players maintain stability and growth in the U.S. sleep apnea devices market.

How This Analysis Helps Clients

• Cost Management: By understanding the tariff landscape, clients can anticipate cost increases and adjust pricing strategies accordingly, ensuring profitability.
• Supply Chain Optimization: Clients can identify alternative sourcing options and diversify their supply chains to reduce dependency on high-tariff regions, enhancing resilience.
• Regulatory Navigation: Expert guidance on navigating the evolving regulatory environment helps clients maintain compliance and avoid potential legal challenges.
• Strategic Planning: Insights into tariff impacts enable clients to make informed decisions about manufacturing locations, partnerships, and market entry strategies.

Key takeaways from the sleep apnea devices market report study

• Market size analysis for the current sleep apnea devices market size (2024), and market forecast for 8 years (2025 to 2032)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
• Key companies dominating the sleep apnea devices market.
• Various opportunities available for the other competitors in the sleep apnea devices market space.
• What are the top-performing segments in 2024? How these segments will perform in 2032?
• Which are the top-performing regions and countries in the current sleep apnea devices market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for the sleep apnea devices market growth in the future?

Frequently Asked Questions for the Sleep Apnea Devices Market

1. What is the growth rate of the sleep apnea devices market?

• The sleep apnea devices market is estimated to grow at a CAGR of 6.58% during the forecast period from 2025 to 2032.

2. What is the market for sleep apnea devices?

• The sleep apnea devices market was valued at USD 9,561.14 million in 2024, and is expected to reach USD 15,839.98 million by 2032.

3. Which region has the highest share in the sleep apnea devices market?

• North America is projected to hold the largest share of the global sleep apnea devices market in 2024, supported by the rising prevalence of sleep apnea and insomnia, the rising geriatric population base in the region, and the rising chronic nasal congestion. Additionally, increased government initiatives coupled with increased awareness programs for sleep apnea disorders, and the presence of key market players engaged in mergers, acquisitions, product launches, and other market activities across the region, are further boosting the overall market of sleep apnea devices.

4. What are the drivers for the sleep apnea devices market?

• The demand for sleep apnea devices is primarily being boosted due to the increasing cases of sleep apnea and the rising population with obesity. Further, the rising adoption of advanced and innovative technologies, the rising awareness about sleep apnea devices, the increasing geriatric population, and the increasing product launches and approvals, among others, are contributing to the overall growth of the sleep apnea devices market during the forecast period from 2025 to 2032.

5. Who are the key players operating in the sleep apnea devices market?

• Some of the key market players operating in the sleep apnea devices market include Koninklijke Philips N.V., ResMed, Fisher & Paykel Healthcare Limited, and AMBULANCE (SHENZHEN) TECH. CO. LTD, BMC, Beijing Aeonmed Co., Ltd., Hebei Topson Medical Technology Co., Ltd., Hunan VentMed Medical Technology Co., Ltd, Vivos Therapeutics, Inc., Guangdong Pigeon Medical Apparatus Co., Ltd., Nihon Kohden Corporation, Natus Medical Incorporated, SOMNOmedics GmbH, VYAIRE, Compumedics Limited, Drive DeVilbiss International, Nox Medical, eXciteOSA Inc., BPL Medical Technologies, Elmaslar Medikal A.S., BMC, and others.

Table of Contents

1. Sleep Apnea Devices Market Report Introduction

• 1.1. Scope of the Study
• 1.2. Market Segmentation
• 1.3. Market Assumption

2. Sleep Apnea Devices Market Executive Summary

• 2.1. Market at Glance

3. Sleep Apnea Devices Market Key Factors Analysis

• 3.1. Sleep Apnea Devices Market Drivers
  • 3.1.1. Increasing prevalence of obstructive sleep apnea devices and associated risk factors
  • 3.1.2. Increasing public health initiatives and awareness campaigns
  • 3.1.3. Technological advancement in product design
  • 3.1.4. Increase in product development activities among the key market players
• 3.2. Sleep Apnea Devices Market Restraints and Challenges
  • 3.2.1. Complications related to implantable sleep apnea devices
  • 3.2.2. High cost of Positive Airway Pressure (PAP) devices
• 3.3. Sleep Apnea Devices Market Opportunity
  • 3.3.1. Integration of artificial intelligence and growing telehealth adoption

4. Impact Analysis

• 4.1. AI-Powered Innovations and Applications
• 4.2. U.S. Tariff Impact Analysis

5. Regulatory Analysis

• 5.1. The United States
• 5.2. Europe
• 5.3. Japan
• 5.4. China

6. Sleep Apnea Devices Market Porter's Five Forces Analysis

• 6.1. Bargaining Power of Suppliers
• 6.2. Bargaining Power of Consumers
• 6.3. Threat of New Entrants
• 6.4. Threat of Substitutes
• 6.5. Competitive Rivalry

7. Sleep Apnea Devices Market Assessment

• 7.1. By Product Type
  • 7.1.1. Therapeutic Device
    • 7.1.1.1. Positive Airway Pressure (PAP)
    • 7.1.1.2. Oral Appliances
    • 7.1.1.3. Oxygen Devices
    • 7.1.1.4. Others
  • 7.1.2. Diagnostic Device
    • 7.1.2.1. Pulse Oximeter
    • 7.1.2.2. Polysomnography Devices (PSG)
    • 7.1.2.3. Actigraphy Devices
• 7.2. By Portability
  • 7.2.1. Portable
  • 7.2.2. Non-Portable
• 7.3. By End-Users
  • 7.3.1. Hospital & Clinics
  • 7.3.2. Home Healthcare
  • 7.3.3. Others
• 7.4. By Geography
  • 7.4.1. North America
    • 7.4.1.1. United States Sleep Apnea Devices Market Size in USD million (2022-2032)
    • 7.4.1.2. Canada Sleep Apnea Devices Market Size in USD million (2022-2032)
    • 7.4.1.3. Mexico Sleep Apnea Devices Market Size in USD million (2022-2032)
  • 7.4.2. Europe
    • 7.4.2.1. France Sleep Apnea Devices Market Size in USD million (2022-2032)
    • 7.4.2.2. Germany Sleep Apnea Devices Market Size in USD million (2022-2032)
    • 7.4.2.3. United Kingdom Sleep Apnea Devices Market Size in USD million (2022-2032)
    • 7.4.2.4. Italy Sleep Apnea Devices Market Size in USD million (2022-2032)
    • 7.4.2.5. Spain Sleep Apnea Devices Market Size in USD million (2022-2032)
    • 7.4.2.6. Rest of Europe Sleep Apnea Devices Market Size in USD million (2022-2032)
  • 7.4.3. Asia-Pacific
    • 7.4.3.1. China Sleep Apnea Devices Market Size in USD million (2022-2032)
    • 7.4.3.2. Japan Sleep Apnea Devices Market Size in USD million (2022-2032)
    • 7.4.3.3. India Sleep Apnea Devices Market Size in USD million (2022-2032)
    • 7.4.3.4. Australia Sleep Apnea Devices Market Size in USD million (2022-2032)
    • 7.4.3.5. South Korea Sleep Apnea Devices Market Size in USD million (2022-2032)
    • 7.4.3.6. Rest of Asia-Pacific Sleep Apnea Devices Market Size in USD million (2022-2032)
  • 7.4.4. Rest of the World (RoW)
    • 7.4.4.1. Middle East Sleep Apnea Devices Market Size in USD million (2022-2032)
    • 7.4.4.2. Africa Sleep Apnea Devices Market Size in USD million (2022-2032)
    • 7.4.4.3. South America Sleep Apnea Devices Market Size In USD Million (2022-2032)

8. Competitive Landscape

9. Startup Funding & Investment Trends

10. Sleep Apnea Devices Market Company and Product Profiles

• 10.1. Koninklijke Philips N.V.
  • 10.1.1. Company Overview
  • 10.1.2. Company Snapshot
  • 10.1.3. Financial Overview
  • 10.1.4. Product Listing
  • 10.1.5. Entropy
• 10.2. ResMed
  • 10.2.1. Company Overview
  • 10.2.2. Company Snapshot
  • 10.2.3. Financial Overview
  • 10.2.4. Product Listing
  • 10.2.5. Entropy
• 10.3. Fisher & Paykel Healthcare Limited
  • 10.3.1. Company Overview
  • 10.3.2. Company Snapshot
  • 10.3.3. Financial Overview
  • 10.3.4. Product Listing
  • 10.3.5. Entropy
• 10.4. AMBULANCE (SHENZHEN) TECH. CO. LTD
  • 10.4.1. Company Overview
  • 10.4.2. Company Snapshot
  • 10.4.3. Financial Overview
  • 10.4.4. Product Listing
  • 10.4.5. Entropy
• 10.5. Beijing Aeonmed Co., Ltd.
  • 10.5.1. Company Overview
  • 10.5.2. Company Snapshot
  • 10.5.3. Financial Overview
  • 10.5.4. Product Listing
  • 10.5.5. Entropy
• 10.6. Hebei Topson Medical Technology Co., Ltd.
  • 10.6.1. Company Overview
  • 10.6.2. Company Snapshot
  • 10.6.3. Financial Overview
  • 10.6.4. Product Listing
  • 10.6.5. Entropy
• 10.7. Hunan VentMed Medical Technology Co., Ltd.
  • 10.7.1. Company Overview
  • 10.7.2. Company Snapshot
  • 10.7.3. Financial Overview
  • 10.7.4. Product Listing
  • 10.7.5. Entropy
• 10.8. Vivos Therapeutics, Inc.
  • 10.8.1. Company Overview
  • 10.8.2. Company Snapshot
  • 10.8.3. Financial Overview
  • 10.8.4. Product Listing
  • 10.8.5. Entropy
• 10.9. Guangdong Pigeon Medical Apparatus Co., Ltd.
  • 10.9.1. Company Overview
  • 10.9.2. Company Snapshot
  • 10.9.3. Financial Overview
  • 10.9.4. Product Listing
  • 10.9.5. Entropy
• 10.10. Nihon Kohden Corporation
  • 10.10.1. Compan Overview
  • 10.10.2. Company Snapshot
  • 10.10.3. Financial Overview
  • 10.10.4. Product Listing
  • 10.10.5. Entropy
• 10.11. Natus Medical Incorporated
  • 10.11.1. Company Overview
  • 10.11.2. Company Snapshot
  • 10.11.3. Financial Overview
  • 10.11.4. Product Listing
  • 10.11.5. Entropy
• 10.12. SOMNOmedics GmbH
  • 10.12.1. Company Overview
  • 10.12.2. Company Snapshot
  • 10.12.3. Financial Overview
  • 10.12.4. Product Listing
  • 10.12.5. Entropy
• 10.13. VYAIRE
  • 10.13.1. Company Overview
  • 10.13.2. Company Snapshot
  • 10.13.3. Financial Overview
  • 10.13.4. Product Listing
  • 10.13.5. Entropy
• 10.14. Compumedics Limited
  • 10.14.1. Company Overview
  • 10.14.2. Company Snapshot
  • 10.14.3. Financial Overview
  • 10.14.4. Product Listing
  • 10.14.5. Entropy
• 10.15. Drive DeVilbiss International
  • 10.15.1. Company Overview
  • 10.15.2. Company Snapshot
  • 10.15.3. Financial Overview
  • 10.15.4. Product Listing
  • 10.15.5. Entropy
• 10.16. Nox Medical
  • 10.16.1. Company Overview
  • 10.16.2. Company Snapshot
  • 10.16.3. Financial Overview
  • 10.16.4. Product Listing
  • 10.16.5. Entropy
• 10.17. eXciteOSA Inc.
  • 10.17.1. Company Overview
  • 10.17.2. Company Snapshot
  • 10.17.3. Financial Overview
  • 10.17.4. Product Listing
  • 10.17.5. Entropy
• 10.18. BPL Medical Technologies
  • 10.18.1. Company Overview
  • 10.18.2. Company Snapshot
  • 10.18.3. Financial Overview
  • 10.18.4. Product Listing
  • 10.18.5. Entropy
• 10.19. Elmaslar Medikal A.S.
  • 10.19.1. Company Overview
  • 10.19.2. Company Snapshot
  • 10.19.3. Financial Overview
  • 10.19.4. Product Listing
  • 10.19.5. Entropy
• 10.20. BMC.
  • 10.20.1. Company Overview
  • 10.20.2. Company Snapshot
  • 10.20.3. Financial Overview
  • 10.20.4. Product Listing
  • 10.20.5. Entropy

11. KOL Views

12. Project Approach

13. About DelveInsight

14. Disclaimer & Contact Us